共有1347例患者随机接受恩替卡韦或拉米夫定治疗。
A total of 1347 patients were randomized to treatment with entecavir or lamivudine.
结论恩替卡韦治疗慢性重型乙型肝炎具有较好的疗效和安全性。
Conclusion it can be concluded that Entecavir has good therapeutic efficiency and safety in the treatment of chronic severe hepatitis b.
在服用恩替卡韦之前，病人血液样本中的艾滋病毒没有M 184v突变。
Blood samples taken from the patient before taking entecavir had no M184V mutations in the HIV.
应用推荐